John Lovett
Wilmington, NCNPI 1114927795
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.1% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $956 and has fallen 98.2% since, to $18 in 2023.
Across 98 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$391
- Astellas Pharma US Inc$346
- Dendreon Pharmaceuticals LLC$199
- Janssen Products, LP$100
- Pfizer$88
- AbbVie$81
- plus $622 from 17 others
What the payments were for
- Food & beverage$1,64690%
- Education$18010%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 15 | $391 |
| Astellas Pharma US Inc | 23 | $346 |
| Dendreon Pharmaceuticals LLC | 10 | $199 |
| Janssen Products, LP | 1 | $100 |
| Pfizer | 7 | $88 |
| AbbVie(2 entities) | 5 | $81 |
| 180 Medical, Inc. | 4 | $69 |
| Ferring Pharmaceuticals Inc. | 5 | $68 |
| Bayer | 4 | $65 |
| Endo Pharmaceuticals Inc. | 4 | $56 |
| Boston Scientific | 2 | $49 |
| Blue Earth Diagnostics | 2 | $48 |
| Coloplast | 3 | $46 |
| Foundation Medicine, Inc. | 2 | $38 |
| Amgen | 2 | $37 |
| Smith+Nephew | 2 | $30 |
| Laborie Medical Technologies Corp. | 1 | $24 |
| Medtronic | 1 | $21 |
| AstraZeneca | 1 | $20 |
| Avadel Specialty Pharmaceuticals, LLC | 1 | $15 |
| Zyla Life Sciences, Inc. | 1 | $14 |
| Hollister Incorporated | 1 | $13 |
| Myriad Genetic Laboratories, Inc. | 1 | $11 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.